HYPERPROLACTINEMIA AND ANTIPSYCHOTIC THERAPY IN SCHIZOPHRENIC PATIENTS WITH HASHIMOTO' S THYROIDITIS

Autor: Sobolevskaia, Polina A., Churilov, Leonid P., Fedotkina, Tamara V., Stepochkina, Anna, Dolina, Anastasia, Gvozdetckii, Anton N., Andreev †, Boris V., Shoenfeld, Yehuda

Publikováno v: Psychiatria Danubina
Volume 33
Issue suppl 4

Introduction: Hyperprolactinemia (HPRL) is known as a side effect of some antidepressants and antipsychotics. These medicines are common in treatment of schizophrenia. Thus, HPRL is often observed in schizophrenic patients. It is also known that HPRL

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______951::41e238e0c6f3a5a18baa01ea6d605856
https://hrcak.srce.hr/274991

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

DOSE-RATE EFFECT IN HIGHLY CORRELATED SOLIDS.

Autor: ANDREEV, BORIS V., KOSTRUBOV, YURY N.

Publikováno v: International Journal of Modern Physics B: Condensed Matter Physics; Statistical Physics; Applied Physics; Aug1991, Vol. 5 Issue 13, p2271-2285, 15p

Corrigenda: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial.

Autor: Patil, Sandeep T, Zhang, Lu, Martenyi, Ferenc, Lowe, Stephen L, Jackson, Kimberley A, Andreev, Boris V, Avedisova, Alla S, Bardenstein, Leonid M, Gurovich, Issak Y, Morozova, Margarita A, Mosolov, Sergey N, Neznanov, Nikolai G, Reznik, Alexander M, Smulevich, Anatoly B, Tochilov, Vladimir A, Johnson, Bryan G, Monn, James A, Schoepp, Darryle D

Publikováno v: Nature Medicine; Oct2007, Vol. 13 Issue 10, p1264-1264, 1p